Agenus
Utility Patents

Last updated:

List of all Agenus patents 29 in total

Status Patent
Grant
Utility: Antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 20 Sep 2022
Grant
Utility: Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies External link
Filling date: 6 Sep 2025 Issue date: 16 Aug 2022
Grant
Utility: Anti-GITR antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 2 Aug 2022
Grant
Utility: Anti-OX40 antibodies and anti-GITR antibodies External link
Filling date: 6 Sep 2025 Issue date: 14 Jun 2022
Grant
Utility: Anti-PD-1 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 31 May 2022
Grant
Utility: Vectors comprising nucleic acids encoding anti-OX40 antibodies External link
Filling date: 6 Sep 2025 Issue date: 17 May 2022
Grant
Utility: Anti-CTLA-4 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 8 Mar 2022
Grant
Utility: Anti-CD137 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 8 Feb 2022
Grant
Utility: Anti-OX40 antibodies External link
Filling date: 6 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: Anti-CD137 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 24 Aug 2021
Grant
Utility: Heat shock protein-binding peptide compositions and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 20 Jul 2021
Grant
Utility: Anti-ILT4 antibodies and antigen-binding fragments External link
Filling date: 6 Sep 2025 Issue date: 6 Jul 2021
Grant
Utility: Anti-TIGIT antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 1 Jun 2021
Grant
Utility: Anti-CTLA-4 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 25 May 2021
Grant
Utility: Anti-CTLA-4 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 9 Feb 2021
Grant
Utility: Anti-TIM-3 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 9 Feb 2021
Grant
Utility: Anti-LAG-3 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 5 Jan 2021
Grant
Utility: Anti-LAG-3 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 24 Nov 2020
Grant
Utility: Antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 17 Nov 2020
Grant
Utility: Anti-GITR antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 10 Nov 2020
Grant
Utility: Anti-GITR antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Anti-TIM-3 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 5 May 2020
Grant
Utility: Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies External link
Filling date: 6 Sep 2025 Issue date: 5 May 2020
Grant
Utility: Nucleic acids encoding anti-OX40 antibodies External link
Filling date: 6 Sep 2025 Issue date: 21 Apr 2020
Grant
Utility: Anti-GITR antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2020
Grant
Utility: Vaccines for treatment and prevention of cancer External link
Filling date: 6 Sep 2025 Issue date: 25 Feb 2020
Grant
Utility: Identification of antigen- or ligand-specific binding proteins External link
Filling date: 6 Sep 2025 Issue date: 10 Dec 2019
Grant
Utility: Anti-CTLA-4 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Anti-PD-1 antibodies and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 22 Oct 2019

Showing 1 to 29 of 29 patents.